Aminocaproic acid and Pramipexole dihydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Aminocaproic acid and Pramipexole dihydrochloride together.

The phase IV clinical study analyzes what interactions people who take Aminocaproic acid and Pramipexole dihydrochloride have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

3 people who take Aminocaproic acid and Pramipexole dihydrochloride together, and have interactions are studied.


What is Aminocaproic acid?

Aminocaproic acid has active ingredients of aminocaproic acid. eHealthMe is studying from 564 Aminocaproic acid users for its effectiveness, alternative drugs and more.

What is Pramipexole dihydrochloride?

Pramipexole dihydrochloride has active ingredients of pramipexole dihydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 4,654 Pramipexole dihydrochloride users for its effectiveness, alternative drugs and more.

Number of Aminocaproic acid and Pramipexole dihydrochloride reports submitted per year:

Aminocaproic acid and Pramipexole dihydrochloride drug interactions.

Common Aminocaproic Acid and Pramipexole Dihydrochloride drug interactions by gender *:

female:

  1. Abdominal pain
  2. Atrioventricular block
  3. Wound dehiscence
  4. Death
  5. Device related infection
  6. Bradycardia
  7. Cardiac arrest
  8. Epistaxis
  9. Escherichia urinary tract infection
  10. Neutropenia

male:

n/a

Common Aminocaproic Acid and Pramipexole Dihydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Device related infection

60+:

  1. Abdominal pain
  2. Atrioventricular block
  3. Wound dehiscence
  4. Death
  5. Bradycardia
  6. Cardiac arrest
  7. Epistaxis
  8. Escherichia urinary tract infection
  9. Neutropenia
  10. Platelet count decreased

* Approximation only. Some reports may have incomplete information.

Do you take Aminocaproic acid and Pramipexole dihydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Aminocaproic acid and Pramipexole dihydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aminocaproic acid interactions:

Browse all interactions between Aminocaproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pramipexole dihydrochloride interactions:

Browse all interactions between Pramipexole dihydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid and pramipexole dihydrochloride (the active ingredients of Aminocaproic acid and Pramipexole dihydrochloride, respectively), and Aminocaproic acid and Pramipexole dihydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Aminocaproic acid and Pramipexole dihydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: